Fortress Biotech, Inc. (FBIOP) Gross margin 2016–2025
Fortress Biotech, Inc. (FBIOP) gross margin by fiscal year — reported gross profit divided by reported revenue.
66.9%FY2025 · since FY2016: 95.2% → 66.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 66.9% | +3.1 pp |
| FY2024 | 63.8% | -9.1 pp |
| FY2023 | 72.9% | +13.5 pp |
| FY2022 | 59.4% | +6.0 pp |
| FY2021 | 53.4% | -14.6 pp |
| FY2020 | 68.0% | -3.3 pp |
| FY2019 | 71.2% | -6.0 pp |
| FY2018 | 77.2% | -1.6 pp |
| FY2017 | 78.8% | -16.4 pp |
| FY2016 | 95.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice